Implementation of REFOCUS Training Program in Mental Health Services
Launched by HÔPITAL LE VINATIER · Apr 19, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a training program called REFOCUS, which aims to help mental health service teams provide better care focused on recovery for patients with various mental disorders. The training lasts for three days and teaches healthcare professionals how to support patients in their journey towards feeling better and regaining control of their lives. After the training, the researchers will evaluate how effective this program is in improving mental health services.
To participate in this trial, individuals need to be between the ages of 15 and 65 and have a diagnosis of certain mental health conditions, such as schizophrenia, bipolar disorder, or severe anxiety and depression. Participants should be French speakers and must be receiving care from a team that has undergone the REFOCUS training. If someone decides to join, they will be asked to sign a consent form to confirm their participation. This trial is currently recruiting participants, so there is an opportunity for eligible individuals to take part and help improve mental health care for others.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age from 15 to 65 years old.
- • Diagnosis of schizophrenia, schizoaffective disorder, schizotypal disorder and schizophreniform disorder or bipolar disorder, borderline personality disorder, disabling anxiety or depressive disorder (DSM-V criteria; APA, 2013).
- • Patients cared for by the team or unit benefiting from REFOCUS training
- • French mother tongue.
- • Patient affiliated or entitled to a social security scheme
- • Patient having received information about the study and having confirmed their participation in the study by signing the consent form
- • For minors (\< 18 years), information given to holders of parental authority and signature of consent.
- • For patients under curatorship, form signed by the patient and information given to the curator
- Exclusion Criteria:
- • Age less than 15 years old
- • Patients under guardianship
- • Presence of an associated intellectual disability
- • Neurological disorders of vascular, infectious or neurodegenerative origin.
- • Taking somatic drugs with a cerebral or psychic impact (eg corticosteroids).
About Hôpital Le Vinatier
Hôpital Le Vinatier is a leading psychiatric hospital located in France, renowned for its commitment to advancing mental health care through innovative research and clinical trials. With a focus on integrating clinical practice and scientific inquiry, the institution aims to enhance treatment protocols and therapeutic outcomes for individuals with psychiatric disorders. Hôpital Le Vinatier collaborates with multidisciplinary teams of healthcare professionals and researchers to conduct rigorous studies, ensuring the highest standards of ethical practice and patient safety. Its dedication to improving mental health services makes it a pivotal player in the field of psychiatric research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lyon, Rhône, France
Lyon, , France
Patients applied
Trial Officials
Julien DUBREUCQ, PH
Principal Investigator
CHU ST ETIENNE
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported